Publications by authors named "Syed J Naqvi"

Background: Poor clinical outcomes and adverse events following orthopaedic trauma are common, which may lead to litigation. To our knowledge, factors associated with litigation following fracture care have not previously been evaluated.

Methods: A retrospective review of fracture-related malpractice lawsuits from 1988 to 2015 was completed utilizing VerdictSearch (ALM Media Properties), a medicolegal database.

View Article and Find Full Text PDF

Liver fibrosis, a form of scarring, develops in chronic liver diseases when hepatocyte regeneration cannot compensate for hepatocyte death. Initially, collagen produced by myofibroblasts (MFs) functions to maintain the integrity of the liver, but excessive collagen accumulation suppresses residual hepatocyte function, leading to liver failure. As a strategy to generate new hepatocytes and limit collagen deposition in the chronically injured liver, we developed in vivo reprogramming of MFs into hepatocytes using adeno-associated virus (AAV) vectors expressing hepatic transcription factors.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Syed J Naqvi"

  • - Syed J Naqvi's research encompasses diverse areas including medical adherence, malpractice in orthopedic trauma, and innovative therapies for liver fibrosis.
  • - His 2021 study in JAMA Cardiology focuses on models to enhance adherence to guideline-directed medical therapy, suggesting implications for improving patient outcomes in cardiovascular care.
  • - Naqvi's investigation into malpractice lawsuits from 1988 to 2015 highlights the factors contributing to litigation following orthopedic trauma, while his 2016 work in Cell Stem Cell explores reprogramming myofibroblasts for potential liver fibrosis therapies utilizing AAV vectors.